Patents Examined by Randall Winston
  • Patent number: 9757423
    Abstract: A method of producing a product to correct hypercholesterolemia including pulping fruits of Emblica officinalis with demineralized water to create a slurry. The slurry is treated with pectinase. The pectinase-treated slurry is filtered to create a solution. The solution is concentrated to create a product. A product having an extract of Emblica officinalis for prophylactic and for therapeutic treatment of coronary diseases, atherosclerosis, hypothyroidism and hyperthyroidism.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: September 12, 2017
    Assignee: ARJUNA NATURAL EXTRACTS, LTD.
    Inventor: Benny Antony
  • Patent number: 9750781
    Abstract: The present invention includes compositions and methods for cleaning, treating, protection and resolution of decubitus ulcers comprising: a first composition comprising a wound cleaning solution comprising aloe vera gel comprising at least 5,000 MPS, a balanced salt solution; and a second composition comprising a wound healing gel comprising aloe vera gel comprising at least 10,000 MPS, a thickening agent, and one or more preservatives and, optionally, a third composition comprising a moisture barrier cream comprising a vegetable-based emulsifier, a cosmetic ester for dry skin that has low occlusivity, an ester-based emollient that is oxidation stable and has low occlusivity; a beeswax; a hydrogenated oil, glycerin, a buffering agent, aloe vera gel comprising at least 2,000 MPS and water.
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: September 5, 2017
    Assignee: Aloe Bioscience, LLC
    Inventor: Ivan E. Danhof
  • Patent number: 9744143
    Abstract: A dihydroxyacetone fortified honey composition, including a mixture of honey and dissolved dihydroxyacetone in a preferred honey to dissolved dihydroxyacetone ratio of 0.5 ml-20 ml of dissolved dihydroxyacetone to each kilogram of honey, wherein the mixture has a moisture content of between one and twenty percent, and wherein the mixture contains a preferred amount of methylglyoxal of between 83 milligrams of methylglyoxal per 1.0 kilogram of honey and 1500 milligrams of methylglyoxal per 1.0 kilogram of honey.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: August 29, 2017
    Assignee: Links Medical Products, Inc.
    Inventors: Thomas L. Buckley, Andrew Thain
  • Patent number: 9737581
    Abstract: The present invention relates to a patch or sticking plaster formulation containing a combination of resveratrol or derivatives thereof and essential oil of cloves (Eugenia caryophyllata) for the treatment of itching.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: August 22, 2017
    Assignee: DIFASS INTERNATIONAL S.R.L.
    Inventors: Alida Agostini, Sonia Balzi
  • Patent number: 9706778
    Abstract: The subject invention provides compositions and methods for treating human dermatological conditions by employing a microbiome-centered treatment approach. Preferred embodiments of the invention provide pharmaceutical and cosmetic compositions, and the methods of using the same, comprising a strain of Lactobacillus fermentum bacterium, or bioactive extracts thereof, derived from human microbiota and capable of growing in biofilm phenotype.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: July 18, 2017
    Assignee: QUORUM INNOVATIONS, LLC
    Inventors: Eva A. Berkes, Nicholas T. Monsul, Frederick T. Boehm
  • Patent number: 9682135
    Abstract: The present invention provides a particulate delivery system comprising an extracted yeast cell wall comprising beta-glucan, a payload molecule and a payload trapping molecule. The invention further provides methods of making and methods of using the particulate delivery system.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: June 20, 2017
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventor: Gary R. Ostroff
  • Patent number: 9682062
    Abstract: The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: June 20, 2017
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: I-Horng Pan, Hsin-Jan Yao, Mei-Wei Lin, I-Huang Lu, Hsin-Chieh Wu, Hsiang-Wen Tseng, Ching-Huai Ko, Chun-Chung Wang, Zong-Keng Kuo, Shyh-Horng Lin, Yi-Cheng Cheng, Tien-Soung Tong
  • Patent number: 9655935
    Abstract: A pharmaceutical composition with an active pharmaceutical ingredient including a pomegranate fruit polyphenol extract. The pomegranate fruit polyphenol extract includes at least about 3% combined punicalagin A and punicalagin B by weight, less than about 5% ellagic acid and their derivatives by weight, and less than about 1% anthocyanins by weight.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: May 23, 2017
    Assignee: POM WONDERFUL, LLC
    Inventors: Mark Dreher, Harley Liker, Yair Steve Henig
  • Patent number: 9629889
    Abstract: An aqueous solution that is useful for helping to increase body temperature in people with chronic low body temperature, as well as people who suffer from cold hands and feet, includes a combination of ginseng, cinnamon, ginger, and jasmine tea. The body temperature raising solution may be in the form of a beverage and include a sweetener, such as honey, to improve the taste thereof. The body temperature raising solution is formulated by steeping leaves of the jasmine tea in a host liquid, suspending predetermined amounts of the ginseng, cinnamon, ginger, and honey into the host liquid, and storing the combination in an airtight container.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: April 25, 2017
    Inventor: Khanh Le
  • Patent number: 9623068
    Abstract: The present invention relates to a composition comprised of a plant extract as an active component, specifically, Bamboo extract and Scutellaria extract, for the treatment and prevention of atopic dermatitis. The present invention is a natural ingredient can be obtained from a plant. The present invention can control immune responses by inhibiting the release of histamine and leukotrien, and thus, has effect in the treatment or prevention of allergic diseases, inflammatory diseases and skin diseases, specifically atopic dermatitis. The present invention has been proven safe and beneficial effecting the treatment of atopic dermatitis through clinical trials, and thus, can be used for the treatment and prevention of atopic dermatitis.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: April 18, 2017
    Assignee: Unigen, Inc.
    Inventors: Sung-Sick Woo, Dong-Seon Kim, Young-Chul Lee, EunJung Son
  • Patent number: 9622964
    Abstract: The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-Ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions associated with the skin. This composition of matter simultaneously inhibits cyclooxygenase (COX) and lipoxygenase (LOX) enzymatic activity in normal, aged and damaged dermal cells and tissues. This invention further provides a method for the prevention and treatment of diseases and conditions of the skin mediated by cyclooxygenase (COX) and lipoxygenase (LOX).
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: April 18, 2017
    Assignee: Unigen, Inc.
    Inventor: Qi Jia
  • Patent number: 9622990
    Abstract: Disclosed is a method for inhibiting cancer cell growth in a subject in need thereof, comprising administering to the subject an effective amount of a compound from Antrodia camphorata, wherein the compound is represented by formula (I): wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.
    Type: Grant
    Filed: October 12, 2015
    Date of Patent: April 18, 2017
    Inventor: Hui Ling Tseng
  • Patent number: 9615600
    Abstract: The invention relates to a method for preparing a dietetic or pharmaceutical composition, comprising the following steps: a) a preparation containing rutin, in particular ground tatary buckwheat, is mixed with a protein solution in a weight ratio protein solution/buckwheat from 1 to 100 (or vice versa), wherein before the addition of buckwheat, the protein solution has been heated above room temperature, b) the mixture from step a) is held for a period of at least 10 to 1,000 s at a temperature >50° C., and c) subsequently to step b), the mixture is cooled down to a temperature below 45° C. The invention further relates to thus obtainable preparations and to the uses thereof.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: April 11, 2017
    Assignee: THANARES GMBH
    Inventors: Hans-Michael Thiede, Wolfgang Kehr
  • Patent number: 9609864
    Abstract: An aqueous disinfectant formulation comprising at least one phenolic compound of natural origin; a surfactant sufficient to form a solution or dispersion of the essential oil in an aqueous carrier; a solvent, and sufficient water to make 100 weight percent is described herein.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: April 4, 2017
    Assignee: LABORATOIRE M2
    Inventors: Francois Daigle, Ann Letellier, Sylvain Quessy
  • Patent number: 9610313
    Abstract: A dietary supplement composition is formulated in a therapeutically effective amount to treat the eye of an individual. The composition includes a perilla seed oil extract, astaxanthin, and at least one carotenoid selected from the group consisting of lutein, trans-zeaxanthin and meso-zeaxanthin.
    Type: Grant
    Filed: May 13, 2014
    Date of Patent: April 4, 2017
    Assignee: U.S. NUTRACEUTICALS
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Patent number: 9603790
    Abstract: The present invention relates to a cosmetic active ingredient for improving the appearance of the skin beneath the eyes. More particularly, the present invention relates to a cosmetic active ingredient comprising an extract of the marine algae, Fucus vesiculosus. The present invention also relates to topical cosmetic compositions comprising as an active component an extract of the marine algae, Fucus vesiculosus, alone or in combination with additional cosmetic active ingredients, to reduce the appearance of dark circles in skin beneath the eye.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: March 28, 2017
    Assignee: BASF CORPORATION
    Inventors: Yuhua Sun, Manasi Chavan
  • Patent number: 9585927
    Abstract: The invention provides a composition comprising a mixture of extracts obtained from Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophylla, and Viola philippica. The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: March 7, 2017
    Assignee: MERIYANA BIO MANAGEMENT B.V.
    Inventor: Chih Hui Lin
  • Patent number: 9572827
    Abstract: A pharmaceutical composition for treating depression and method for preparation thereof is provided. The pharmaceutical composition includes Radix Ginseng, Radix Glycyrrhizae, and/or their aqueous or alcoholic extract. Fructus Jujubae or their aqueous or alcoholic extract can also be included in the pharmaceutical composition.
    Type: Grant
    Filed: November 11, 2013
    Date of Patent: February 21, 2017
    Assignees: Beijing Wonner Biotech. Ltd. Co.
    Inventor: Zuoguang Zhang
  • Patent number: 9532965
    Abstract: A Salvia hispanica L. derived seed oil extract composition of matter containing from 60-88% PUFAs in a ratio of from 3.1:1-3.3:1 of ALA to LA, 4-10% of C-18 mono-unsaturated fatty acid, 1-5% of C-18 saturated fatty acid and 4-8% of C-16 saturated fatty acid in a mixed triglyceride form stable at room temperature of 12-24 months containing a mixture of selected antioxidants.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: January 3, 2017
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Patent number: 9521844
    Abstract: Disclosed are methods for treating catmint oil. The treated catmint oil can be used for the production of hydrogenated catmint oil, which is enriched in the insect repellent, dihydronepetalactone, and from which formulated products may be prepared.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: December 20, 2016
    Assignee: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: John Charles Fisher, Keith W Hutchenson, Scott Christopher Jackson, Leo Ernest Manzer, Mark A Scialdone, Mayis Seapan